BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15721249)

  • 1. OS-9: another piece in the HIF complex story.
    Flashman E; McDonough MA; Schofield CJ
    Mol Cell; 2005 Feb; 17(4):472-3. PubMed ID: 15721249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha.
    Baek JH; Mahon PC; Oh J; Kelly B; Krishnamachary B; Pearson M; Chan DA; Giaccia AJ; Semenza GL
    Mol Cell; 2005 Feb; 17(4):503-12. PubMed ID: 15721254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
    Masson N; Ratcliffe PJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3041-9. PubMed ID: 12829734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
    Callapina M; Zhou J; Schnitzer S; Metzen E; Lohr C; Deitmer JW; Brüne B
    Exp Cell Res; 2005 May; 306(1):274-84. PubMed ID: 15878351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
    Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ
    Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
    Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
    Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
    Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
    IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress.
    Salnikow K; Donald SP; Bruick RK; Zhitkovich A; Phang JM; Kasprzak KS
    J Biol Chem; 2004 Sep; 279(39):40337-44. PubMed ID: 15271983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product.
    Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L
    J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proline hydroxylation and gene expression.
    Kaelin WG
    Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of von Hippel-Lindau hereditary cancer syndrome: implications of oxygen sensing.
    Yang H; Ivan M; Min JH; Kim WY; Kaelin WG
    Methods Enzymol; 2004; 381():320-35. PubMed ID: 15063684
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases.
    Metzen E; Zhou J; Jelkmann W; Fandrey J; Brüne B
    Mol Biol Cell; 2003 Aug; 14(8):3470-81. PubMed ID: 12925778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.
    Aprelikova O; Chandramouli GV; Wood M; Vasselli JR; Riss J; Maranchie JK; Linehan WM; Barrett JC
    J Cell Biochem; 2004 Jun; 92(3):491-501. PubMed ID: 15156561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.
    Groulx I; Lee S
    Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases.
    Cho H; Park H; Yang EG
    Biochem Biophys Res Commun; 2005 Nov; 337(1):275-80. PubMed ID: 16182243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
    Epstein AC; Gleadle JM; McNeill LA; Hewitson KS; O'Rourke J; Mole DR; Mukherji M; Metzen E; Wilson MI; Dhanda A; Tian YM; Masson N; Hamilton DL; Jaakkola P; Barstead R; Hodgkin J; Maxwell PH; Pugh CW; Schofield CJ; Ratcliffe PJ
    Cell; 2001 Oct; 107(1):43-54. PubMed ID: 11595184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell biology. How cells endure low oxygen.
    Marx J
    Science; 2004 Mar; 303(5663):1454-6. PubMed ID: 15001751
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K; Makino Y; Pereira T; Poellinger L
    EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of hypoxia-inducible factor-1alpha is limited by transcription-dependent depletion.
    Demidenko ZN; Rapisarda A; Garayoa M; Giannakakou P; Melillo G; Blagosklonny MV
    Oncogene; 2005 Jul; 24(30):4829-38. PubMed ID: 15897903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.